Do stable non–ST-segment elevation acute coronary syndromes require admission to coronary care units? - 12/05/16
, Meng Lin, MSc c, Jeffrey A. Bakal, PhD b, c, Finlay A. McAlister, MD, MSc b, c, d, Padma Kaul, PhD b, Jason N. Katz, MD, MHS e, Christopher B. Fordyce, MD, MSc f, Danielle A. Southern, MSc g, Michelle M. Graham, MD h, Stephen B. Wilton, MD, MSc i, L. Kristin Newby, MD, MHS f, Christopher B. Granger, MD f, Justin A. Ezekowitz, MBBCh, MSc b, hRésumé |
Background |
Clinical practice guidelines recommend admitting patients with stable non–ST-segment elevation acute coronary syndrome (NSTE ACS) to telemetry units, yet up to two-thirds of patients are admitted to higher-acuity critical care units (CCUs). The outcomes of patients with stable NSTE ACS initially admitted to a CCU vs a cardiology ward with telemetry have not been described.
Methods |
We used population-based data of 7,869 patients hospitalized with NSTE ACS admitted to hospitals in Alberta, Canada, between April 1, 2007, and March 31, 2013. We compared outcomes among patients initially admitted to a CCU (n=5,141) with those admitted to cardiology telemetry wards (n=2,728).
Results |
Patients admitted to cardiology telemetry wards were older (median 69 vs 65years, P<.001) and more likely to be female (37.2% vs 32.1%, P<.001) and have a prior myocardial infarction (14.3% vs 11.5%, P<.001) compared with patients admitted to a CCU. Patients admitted directly to cardiology telemetry wards had similar hospital stays (6.2 vs 5.7days, P=.29) and fewer cardiac procedures (40.3% vs 48.5%, P<.001) compared with patients initially admitted to CCUs. There were no differences in the frequency of in-hospital mortality (1.3% vs 1.2%, adjusted odds ratio [aOR] 1.57, 95% CI 0.98-2.52), cardiac arrest (0.7% vs 0.9%, aOR 1.37, 95% CI 0.94-2.00), 30-day all-cause mortality (1.6% vs 1.5%, aOR 1.50, 95% CI 0.82-2.75), or 30-day all-cause postdischarge readmission (10.6% vs 10.8%, aOR 1.07, 95% CI 0.90-1.28) between cardiology telemetry ward and CCU patients. Results were similar across low-, intermediate-, and high-risk Duke Jeopardy Scores, and in patients with non–ST-segment myocardial infarction or unstable angina.
Conclusions |
There were no differences in clinical outcomes observed between patients with NSTE ACS initially admitted to a ward or a CCU. These findings suggest that stable NSTE ACS may be managed appropriately on telemetry wards and presents an opportunity to reduce hospital costs and critical care capacity strain.
Le texte complet de cet article est disponible en PDF.Plan
| This work was generated from the University of Alberta. |
Vol 175
P. 184-192 - mai 2016 Retour au numéro
Article précédent
- History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial
- Raffaele De Caterina, Ulrika Andersson, John H. Alexander, Sana M. Al-Khatib, M. Cecilia Bahit, Shinya Goto, Michael Hanna, Claes Held, Stefan Hohnloser, Elaine M. Hylek, Fernando Lanas, Renato D. Lopes, José López-Sendón, Giulia Renda, John Horowitz, Christopher B. Granger, Lars Wallentin, ARISTOTLE Investigators
- Directions for future trials on blood glucose-lowering drugs to improve left ventricular function post–ST-segment elevation myocardial infarction
- Peter Ruben van Dijk, Mohamed Mouden, Renicus Hermanides
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?